Global Insulin Pen and Pump Market Research Report 2021

1 Insulin Pen and Pump Market Overview

• 1.1 Product Overview and Scope of Insulin Pen and Pump
• 1.2 Insulin Pen and Pump Segment by Type
  • 1.2.1 Global Insulin Pen and Pump Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Insulin Pens
  • 1.2.3 Insulin Pump
• 1.3 Insulin Pen and Pump Segment by Application
  • 1.3.1 Insulin Pen and Pump Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital & Clinic
  • 1.3.3 Retail Pharmacy
  • 1.3.4 Online Sales
• 1.4 Global Insulin Pen and Pump Market Size Estimates and Forecasts
  • 1.4.1 Global Insulin Pen and Pump Revenue 2016-2027
  • 1.4.2 Global Insulin Pen and Pump Sales 2016-2027
  • 1.4.3 Insulin Pen and Pump Market Size by Region: 2016 Versus 2021 Versus 2027

2 Insulin Pen and Pump Market Competition by Manufacturers

• 2.1 Global Insulin Pen and Pump Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Insulin Pen and Pump Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Insulin Pen and Pump Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Insulin Pen and Pump Manufacturing Sites, Area Served, Product Type
• 2.5 Insulin Pen and Pump Market Competitive Situation and Trends
  • 2.5.1 Insulin Pen and Pump Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Insulin Pen and Pump Players Market Share by Revenue
  • 2.5.3 Global Insulin Pen and Pump Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Insulin Pen and Pump Retrospective Market Scenario by Region

• 3.1 Global Insulin Pen and Pump Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Insulin Pen and Pump Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Insulin Pen and Pump Market Facts & Figures by Country
  • 3.3.1 North America Insulin Pen and Pump Sales by Country
  • 3.3.2 North America Insulin Pen and Pump Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Insulin Pen and Pump Market Facts & Figures by Country
  • 3.4.1 Europe Insulin Pen and Pump Sales by Country
  • 3.4.2 Europe Insulin Pen and Pump Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Insulin Pen and Pump Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Insulin Pen and Pump Sales by Region
  • 3.5.2 Asia Pacific Insulin Pen and Pump Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Insulin Pen and Pump Market Facts & Figures by Country
  • 3.6.1 Latin America Insulin Pen and Pump Sales by Country
  • 3.6.2 Latin America Insulin Pen and Pump Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Insulin Pen and Pump Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Insulin Pen and Pump Sales by Country
  • 3.7.2 Middle East and Africa Insulin Pen and Pump Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Insulin Pen and Pump Historic Market Analysis by Type

• 4.1 Global Insulin Pen and Pump Sales Market Share by Type (2016-2021)
• 4.2 Global Insulin Pen and Pump Revenue Market Share by Type (2016-2021)
• 4.3 Global Insulin Pen and Pump Price by Type (2016-2021)

5 Global Insulin Pen and Pump Historic Market Analysis by Application

• 5.1 Global Insulin Pen and Pump Sales Market Share by Application (2016-2021)
• 5.2 Global Insulin Pen and Pump Revenue Market Share by Application (2016-2021)
• 5.3 Global Insulin Pen and Pump Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Novo Nordisk
  • 6.1.1 Novo Nordisk Corporation Information
  • 6.1.2 Novo Nordisk Description and Business Overview
  • 6.1.3 Novo Nordisk Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Novo Nordisk Product Portfolio
  • 6.1.5 Novo Nordisk Recent Developments/Updates
• 6.2 Eli Lilly
  • 6.2.1 Eli Lilly Corporation Information
  • 6.2.2 Eli Lilly Description and Business Overview
  • 6.2.3 Eli Lilly Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Eli Lilly Product Portfolio
  • 6.2.5 Eli Lilly Recent Developments/Updates
• 6.3 Sanofi
  • 6.3.1 Sanofi Corporation Information
  • 6.3.2 Sanofi Description and Business Overview
  • 6.3.3 Sanofi Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Sanofi Product Portfolio
  • 6.3.5 Sanofi Recent Developments/Updates
• 6.4 BD
  • 6.4.1 BD Corporation Information
  • 6.4.2 BD Description and Business Overview
  • 6.4.3 BD Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 BD Product Portfolio
  • 6.4.5 BD Recent Developments/Updates
• 6.5 Ypsomed Holding
  • 6.5.1 Ypsomed Holding Corporation Information
  • 6.5.2 Ypsomed Holding Description and Business Overview
  • 6.5.3 Ypsomed Holding Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Ypsomed Holding Product Portfolio
  • 6.5.5 Ypsomed Holding Recent Developments/Updates
• 6.6 Dongbao
  • 6.6.1 Dongbao Corporation Information
  • 6.6.2 Dongbao Description and Business Overview
  • 6.6.3 Dongbao Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Dongbao Product Portfolio
  • 6.6.5 Dongbao Recent Developments/Updates
• 6.7 Owen Mumford
  • 6.6.1 Owen Mumford Corporation Information
  • 6.6.2 Owen Mumford Description and Business Overview
  • 6.6.3 Owen Mumford Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Owen Mumford Product Portfolio
  • 6.7.5 Owen Mumford Recent Developments/Updates
• 6.8 Ganlee
  • 6.8.1 Ganlee Corporation Information
  • 6.8.2 Ganlee Description and Business Overview
  • 6.8.3 Ganlee Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Ganlee Product Portfolio
  • 6.8.5 Ganlee Recent Developments/Updates
• 6.9 Medtronic
  • 6.9.1 Medtronic Corporation Information
  • 6.9.2 Medtronic Description and Business Overview
  • 6.9.3 Medtronic Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Medtronic Product Portfolio
  • 6.9.5 Medtronic Recent Developments/Updates
• 6.10 Roche
  • 6.10.1 Roche Corporation Information
  • 6.10.2 Roche Description and Business Overview
  • 6.10.3 Roche Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Roche Product Portfolio
  • 6.10.5 Roche Recent Developments/Updates
• 6.11 Insulet Corp
  • 6.11.1 Insulet Corp Corporation Information
  • 6.11.2 Insulet Corp Insulin Pen and Pump Description and Business Overview
  • 6.11.3 Insulet Corp Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Insulet Corp Product Portfolio
  • 6.11.5 Insulet Corp Recent Developments/Updates
• 6.12 Tandem Diabetes care
  • 6.12.1 Tandem Diabetes care Corporation Information
  • 6.12.2 Tandem Diabetes care Insulin Pen and Pump Description and Business Overview
  • 6.12.3 Tandem Diabetes care Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Tandem Diabetes care Product Portfolio
  • 6.12.5 Tandem Diabetes care Recent Developments/Updates
• 6.13 Valeritas
  • 6.13.1 Valeritas Corporation Information
  • 6.13.2 Valeritas Insulin Pen and Pump Description and Business Overview
  • 6.13.3 Valeritas Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Valeritas Product Portfolio
  • 6.13.5 Valeritas Recent Developments/Updates
• 6.14 SOOIL
  • 6.14.1 SOOIL Corporation Information
  • 6.14.2 SOOIL Insulin Pen and Pump Description and Business Overview
  • 6.14.3 SOOIL Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 SOOIL Product Portfolio
  • 6.14.5 SOOIL Recent Developments/Updates
• 6.15 Microport
  • 6.15.1 Microport Corporation Information
  • 6.15.2 Microport Insulin Pen and Pump Description and Business Overview
  • 6.15.3 Microport Insulin Pen and Pump Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Microport Product Portfolio
  • 6.15.5 Microport Recent Developments/Updates

7 Insulin Pen and Pump Manufacturing Cost Analysis

• 7.1 Insulin Pen and Pump Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Insulin Pen and Pump
• 7.4 Insulin Pen and Pump Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Insulin Pen and Pump Distributors List
• 8.3 Insulin Pen and Pump Customers

9 Insulin Pen and Pump Market Dynamics

• 9.1 Insulin Pen and Pump Industry Trends
• 9.2 Insulin Pen and Pump Growth Drivers
• 9.3 Insulin Pen and Pump Market Challenges
• 9.4 Insulin Pen and Pump Market Restraints

10 Global Market Forecast

• 10.1 Insulin Pen and Pump Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Insulin Pen and Pump by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Insulin Pen and Pump by Type (2022-2027)
• 10.2 Insulin Pen and Pump Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Insulin Pen and Pump by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Insulin Pen and Pump by Application (2022-2027)
• 10.3 Insulin Pen and Pump Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Insulin Pen and Pump by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Insulin Pen and Pump by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List